Form 4: AN2 Therapeutics Director Reports Stock Transaction
Insider Transaction (Form 4)
Joseph S Zakrzewski, a Director of AN2 Therapeutics, Inc., reported a transaction in 405,880 shares of common stock on August 14, 2026.
Summary
- Bona fide gift: disposed of 405,880 Common Stock on August 14, 2026 (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Joseph S Zakrzewski — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Bona fide gift | Common Stock | 405,880 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Bona fide gift (405,880 shares) |
Keywords
insider transaction, Form 4, ANTX, AN2 Therapeutics, Inc., neutral, Joseph S Zakrzewski
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.